Administration occupational activities
Massive Layoffs Sweep Federal Health Agencies: Thousands of Workers Impacted Across HHS
HHS layoffs, federal health agencies, probationary workers, Trump administration, workforce reduction, CDC, NIH, FDA, CMS
Mass Layoffs at HHS: Trump Administration Cuts Thousands of Probationary Workers
HHS layoffs, probationary employees, Trump administration, CDC, NIH, FDA, federal workforce reduction, public health impact
Robert F. Kennedy Jr. Confirmed as HHS Secretary in Close Senate Vote
RFK Jr., HHS Secretary, Senate confirmation, Trump administration, vaccine skepticism, healthcare policy, Make America Healthy Again
Federal Judge Issues Nationwide Injunction on NIH Funding Cuts After Multi-State Lawsuit
NIH funding, research grants, federal judge, temporary restraining order, lawsuit, indirect costs, Trump administration
Federal Judge Orders Trump Administration to Comply with Ruling Against Federal Funding Freeze
federal funding freeze, court order violation, Judge John McConnell, Trump administration, state attorneys general, federal grants, compliance
Trump Administration Targets Massive Cuts to Federal Health Workforce
federal health workers, layoffs, Trump administration, HHS, FDA, healthcare agencies, workforce reduction, government downsizing
Senator Cassidy’s Crucial Vote Advances RFK Jr.’s HHS Secretary Nomination
Robert F. Kennedy Jr., Bill Cassidy, HHS Secretary nomination, Senate Finance Committee, vaccine safety, public health, Trump administration
Astellas Pharma Announces Major Management Restructuring Amid Strong Financial Performance
Astellas Pharma, management restructuring, financial results, executive appointments, pharmaceutical industry
AstraZeneca Cancels £450 Million UK Vaccine Plant Expansion Amid Government Funding Reduction
AstraZeneca, vaccine manufacturing, UK investment, government funding, Labour administration, economic growth, pharmaceutical industry
2025 J.P. Morgan Healthcare Conference: Optimism, Innovation, and Shifting Landscapes
AI in healthcare, outpatient care expansion, pharmaceutical services, regulatory environment, deal activity, digital health, gene editing, Trump administration